MIRA•benzinga•
EXCLUSIVE: MIRA Pharmaceuticals Tells Benzinga Co. Reports No Brain Toxicity In FDA-Required Study Of Ketamir-2, Says Confirming Absence Of Ketamine-Linked Neurotoxicity
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga